Harbor Capital Advisors Increases Bio-Rad Labs Position as Institutional Ownership Grows

In the quiet arithmetic of institutional confidence, Bio-Rad Laboratories drew fresh capital from professional investors during the second quarter of 2025, as the medical research company's earnings — beating expectations by a wide margin — offered a rare signal of operational clarity in an uncertain market. The accumulation of shares by Harbor Capital Advisors and a constellation of smaller funds reflects a broader human tendency to follow evidence of discipline and growth, even when the broader market remains ambivalent. Bio-Rad, a maker of life science tools and diagnostic products spanning